Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04236336 · ClinicalTrials.gov registry record
A Clinical Study of the TSV Dental Implant System
A clinical trial, sponsored by ZimVie.
- Completed
- Registry status
- 104
- Enrollment target
NCT04236336: Completed study, sponsored by ZimVie.
NCT04236336 is a clinical trial that has completed, run by ZimVie. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04236336 has completed, sponsored by ZimVie.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
This will be a prospective, randomized, observational study. All implants will be placed in either the maxilla or mandible and loaded within 2 months with a provisional or definitive prosthesis. The implants will be evaluated yearly for 2 years.
Primary Outcome
The average change in outcome (implant survival) from baseline (time of exposure or implant placement surgery) to the end of study (2 years) will be analyzed (at the implant level).
Interventions
- DEVICE TSV dental implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2024-07-01 |
What the finished NCT04236336 record still lists
NCT04236336 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which TSV dental implant is the first listed.
NCT04236336 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04236336 about?
NCT04236336 is a clinical study titled "A Clinical Study of the TSV Dental Implant System". This will be a prospective, randomized, observational study. All implants will be placed in either the maxilla or mandible and loaded within 2 months with a provisional or definitive prosthesis. The implants will be evaluated yearly for 2 years.
What is the current status of trial NCT04236336?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2019-10-01. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT04236336?
The interventions under investigation include: TSV dental implant (DEVICE).
Who is sponsoring clinical trial NCT04236336?
This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI